Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues - a Randomized, Double-blind, Placebo-controlled Trial
Latest Information Update: 25 Jul 2024
At a glance
- Drugs Dulaglutide (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Acronyms SKIP
- 03 Jun 2024 Results of a predefined secondary analysis assessing blood pressure changes during smoking cessation in dulaglutide versus placebo treated individuals presented at the 33rd European meeting on hypertension and cardiovascular protection
- 20 Apr 2023 Results assessing the GLP-1 analogue dulaglutide as a new therapy for smoking cessation, published in the Trials.
- 07 Sep 2022 Status changed from active, no longer recruiting to completed.